Literature DB >> 31915259

The Orphan Immune Receptor LILRB3 Modulates Fc Receptor-Mediated Functions of Neutrophils.

Yuxi Zhao1,2,3, Esther van Woudenbergh1, Jing Zhu4,5,6,7, Albert J R Heck4,5,6,7, Kok P M van Kessel1, Carla J C de Haas1, Piet C Aerts1, Jos A G van Strijp1, Alex J McCarthy8,9.   

Abstract

Neutrophils are critical to the generation of effective immune responses and for killing invading microbes. Paired immune receptors provide important mechanisms to modulate neutrophil activation thresholds and effector functions. Expression of the leukocyte Ig-like receptor (LILR)A6 (ILT8/CD85b) and LILRB3 (ILT5/CD85a) paired-receptor system on human neutrophils has remained unclear because of the lack of specific molecular tools. Additionally, there is little known of their possible functions in neutrophil biology. The objective of this study was to characterize expression of LILRA6/LILRB3 receptors during human neutrophil differentiation and activation, and to assess their roles in modulating Fc receptor-mediated effector functions. LILRB3, but not LILRA6, was detected in human neutrophil lysates following immunoprecipitation by mass spectrometry. We demonstrate high LILRB3 expression on the surface of resting neutrophils and release from the surface following neutrophil activation. Surface expression was recapitulated in a human PLB-985 cell model of neutrophil-like differentiation. Continuous ligation of LILRB3 inhibited key IgA-mediated effector functions, including production of reactive oxygen species, phagocytic uptake, and microbial killing. This suggests that LILRB3 provides an important checkpoint to control human neutrophil activation and their antimicrobial effector functions during resting and early-activation stages of the neutrophil life cycle.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31915259     DOI: 10.4049/jimmunol.1900852

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Tumor-derived immunoglobulin like transcript 5 induces suppressive immunocyte infiltration in colorectal cancer.

Authors:  Wenjing Shi; Fang Zhang; Xiaozheng Chen; Shuyun Wang; Haiqin Zhang; Zijiang Yang; Guiying Wang; Yan Zheng; Yali Han; Yuping Sun; Aiqin Gao
Journal:  Cancer Sci       Date:  2022-04-28       Impact factor: 6.518

2.  Group B Streptococcus Surface Protein β: Structural Characterization of a Complement Factor H-Binding Motif and Its Contribution to Immune Evasion.

Authors:  Xin Xu; Alexander L Lewis Marffy; Andrew Keightley; Alex J McCarthy; Brian V Geisbrecht
Journal:  J Immunol       Date:  2022-02-02       Impact factor: 5.422

3.  Computational Analysis of the Immune Infiltration Pattern and Candidate Diagnostic Biomarkers in Lumbar Disc Herniation.

Authors:  Kai Li; Shijue Li; Haojie Zhang; Di Lei; Wai Leung Ambrose Lo; Minghui Ding
Journal:  Front Mol Neurosci       Date:  2022-04-21       Impact factor: 5.639

Review 4.  Leukocyte Immunoglobulin-Like Receptors (LILRs) on Human Neutrophils: Modulators of Infection and Immunity.

Authors:  Alexander L Lewis Marffy; Alex J McCarthy
Journal:  Front Immunol       Date:  2020-05-13       Impact factor: 7.561

Review 5.  Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.

Authors:  Mi Deng; Heyu Chen; Xiaoye Liu; Ryan Huang; Yubo He; Byounggyu Yoo; Jingjing Xie; Samuel John; Ningyan Zhang; Zhiqiang An; Cheng Cheng Zhang
Journal:  Antib Ther       Date:  2021-02-09

6.  Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors.

Authors:  Nina M van Sorge; Daniel A Bonsor; Liwen Deng; Erik Lindahl; Verena Schmitt; Mykola Lyndin; Alexej Schmidt; Olof R Nilsson; Jaime Brizuela; Elena Boero; Eric J Sundberg; Jos A G van Strijp; Kelly S Doran; Bernhard B Singer; Gunnar Lindahl; Alex J McCarthy
Journal:  EMBO J       Date:  2021-02-01       Impact factor: 11.598

Review 7.  Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics.

Authors:  Florence Abdallah; Sixtine Coindre; Margaux Gardet; Florian Meurisse; Abderrahim Naji; Narufumi Suganuma; Laurent Abi-Rached; Olivier Lambotte; Benoit Favier
Journal:  Front Immunol       Date:  2021-09-14       Impact factor: 7.561

Review 8.  Human inhibitory leukocyte Ig-like receptors: from immunotolerance to immunotherapy.

Authors:  Calvin D De Louche; Ali Roghanian
Journal:  JCI Insight       Date:  2022-01-25

Review 9.  Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?

Authors:  Chilam Chan; Marta Lustig; Niklas Baumann; Thomas Valerius; Geert van Tetering; Jeanette H W Leusen
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

10.  LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation.

Authors:  Muchaala Yeboah; Charys Papagregoriou; Des C Jones; H T Claude Chan; Guangan Hu; Justine S McPartlan; Torbjörn Schiött; Ulrika Mattson; C Ian Mockridge; Ulla-Carin Tornberg; Björn Hambe; Anne Ljungars; Mikael Mattsson; Ivo Tews; Martin J Glennie; Stephen M Thirdborough; John Trowsdale; Björn Frendeus; Jianzhu Chen; Mark S Cragg; Ali Roghanian
Journal:  JCI Insight       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.